Follow us : Twitter LinkedIn
Conseils en Propriété Industrielle / European Patent and Trademark Attorneys
Client Login
Home > Publications > Search for a publication

Our publications

Search a publication

Title of Intellectual Property
Patents
European and Unitary Patent
US Patent
Trademark
European Union trademark
International Trademark
Design
Domain names
Software
Copyright
Theme
Health
Digital
Strategy
Patentability of Biological Material
Arbitration and Mediation
Contracts
Infringement
Regulation, Labelling
Data
Wine and Spirits
Pharmacy
Well-known TM, Dilution, Use
Accelerated Examination
European patent
Immunotherapy
PACTE Law
Biodiversity
Brexit
Biomarkers
Author name

Search result

 84 publications

Changes to USPTO Fees Effective October 2
By Bailey Ziegler, US Patent Attorney.
Ziegler_Search.jpg We would like to inform you that fee changes are being implemented by the US Patent and Trademark Office (“USPTO”) and take effect on October 2, 2020. On average, patent fees are increasing by approximately 5%.
Published on: 25th Sept 2020

Patent

Brexit will become a reality on January 1st, 2021
By Evelyne ROUX, Partner.
ROUX_SEARCH_2013.jpg On January 1st, 2021, the transition period which followed the UK’s decision to leave the EU will end, a priori without any further extension. When deciding your budget, in particular for renewals, remember the measures that will need to be taken to anticipate the effects of BREXIT and the consequences for your intellectual property rights.
Published on: 22th Sept 2020

Patent

Trademark

Designs

Brexit

Copyright

Infringement

COVID-19: New free patent panorama databases are being launched
By Isabelle MARY, Head of the IP Intelligence Department, French Patent Attorney
I.Mary.jpg In the turbulent context of the fight against COVID-19, while patent protection of innovations has been at the heart of controversy, it has also been a source of positive collaboration between research teams. A number of patent information platforms have been created, indexing specific data on the subject and enabling the innovative community to carry out relevant searches in a targeted and structured corpus.
Published on: 19th Aug 2020

Patent

Digital

JUB : Breaking news !
By Stéphanie CELAIRE, Partner and French & European Patent Attorney
Celaire_search.jpg Neither Brexit nor Covid-19 seems to have hindered the motivation of the European Commission (EC) to see the project of the Unified Patent Court (UPC) and the Unitary Patent realized.
Published on: 23th Jul 2020

Patent

Unitary Patent

A conflict? A relational difficulty? Think mediation!
Frédérique FAIVRE PETIT, Partner, French Patent Attorney & European Patent Attorney
Faivre-Petit_search.jpg Are you an entrepreneur, a head of service, a project coordinator? You need to dedicate yourself to the recovery and development of your activity. You do not have enough time available to settle conflicts, disputes or litigations, more or less important, potential or occurring as a part of your activities. You wish to avoid initiating a legal action.
Published on: 22th Jun 2020

Patent

Arbitration and Mediation

G3/19: Products exclusively obtained by an essentially biological method finally excluded from patentability
Philippe BESSIERE, French & European Patent Attorney
BESSIERE_SEARCH.jpg G3/19 concerns a referral to the Enlarged Board of Appeal by the President of the European Patent Office (EPO) following decision T1063/18 (Pepper) by a Board of Appeal which concluded that Rule 28 (2) EPC, prohibiting the grant of a European patent for plants obtained exclusively by an essentially biological process, was in conflict with the previous interpretation of Article 53 (c) EPC by the Enlarged Board of Appeal in decisions G 2/12 and G 2/13 (Brocoli / Tomato).
Published on: 3rd Jun 2020

Patent

Patentability of Biological Material

Plant Breeding

EPO extends possibility of oral proceedings by videoconference to opposition proceedings
By Jerôme COLLIN, Partner, French & European Patent Attorney.
Collin_search.jpg It has been possible to hold oral proceedings by videoconference at the EPO since 1998. This has opened an interesting possibility for applicants and their representatives, allowing applicants to attend the oral proceedings without having to travel to the premises of the EPO. Regimbeau has been using this possibility routinely for years.
Published on: 30th April 2020

Patent

Digital

Unified Patent Court - the German federal Constitutional court has finally issued its decision regarding the ratification process in Germany
By Sylvain THIVILLIER Partner and French & European Patent Attorney and Henri BOURGEOIS, French & European Patent Attorney.
On Friday March 20, 2020, the German Federal Constitutional Court issued its decision relating to the appeal filed against the German Act of Approval of the Unified Patent Court (“UPC”), and ruled that the vote at the German Parliament in favour of the ratification was not valid.
Published on: 23th March 2020

Patent

European and Unitary Patent

PACTE Law: Opposition to patents
By Stéphanie CELAIRE, Partner and French & European Patent Attorney, and Henri BOURGEOIS, French & European Patent Attorney.
CELAIREBOURGEOIS.png The 2019 PACTE Law will deeply modify several fundamental aspects of the French patent law. One of the flagship measures in this area is undoubtedly the creation of patent opposition proceedings before the French IP Office, with the right to appeal before the Paris Court of Appeal.
Published on: 17th March 2020

Patent

Opposition

PACTE Law

PACTE LAW: changes relating to Utility Certificates and establishment of a provisional patent application
By Stéphanie CELAIRE, Partner
Celaire_search.jpg The PACTE Law of 2019 will result in substantial changes to several fundamental aspects of French patent law. This law extends the term of protection conferred by utility certificates and establishes a provisional patent application. When developing your industrial property strategy, these provisions should be considered as a package deal along with the examination of inventive step of patent applications and new opposition proceedings.
Published on: 10th Feb 2020

Patent

Opposition

PACTE Law

PACTE law: changes relating to examination of French patent applications
By Henri BOURGEOIS, French & European Patent Attorney.
BOURGEOIS_SEARCH.jpg The PACTE law of 2019 will result in substantial changes to several fundamental aspects of French patent law. Concerning the examination of French patent applications, in addition to the key measure that is examination of inventive step, several existing grounds of rejection are being reinforced and a new ground of rejection for extension beyond the content of the application as-filed is being introduced. Provisions concerning national security are also modified.
Published on: 4th Feb 2020

Patent

PACTE Law

AI Inventors: the European Patent Office sets the record straight in the DABUS decision.
By Matthieu OBJOIS, Senior Associate, and Lucas ROBIN, Patent Engineer.
After a long-awaited oral procedure, the EPO logically indicated that only natural persons could be designated as inventors in a European patent application, even if artificial intelligence algorithms were involved.
Published on: 4th Feb 2020

Patent

AI

The NEURIM approach may be restricted or even dismissed. Once again, an advocate general recommends a reversal of jurisprudence. What will the Court's position ultimately be?
By Anne BOUTARIC, Partner.
BOUTARIC_SEARCH.jpg The NEURIM decision opened the possibility to grant SPC for subsequent therapeutic indications of a known active ingredient. This decision, comprising indefinite concepts subject to interpretation, has undermined the objective that Regulation No 469/2009 is uniformly implemented within the European Union. Three requests for a preliminary ruling have since been lodged at the Court of Justice of the European Union leading to the Abraxis judgment delivered on March 21, 2019 and to the Santen case, C-673/18, in progress, in which the Advocate General delivered its opinion on January 23, 2020. The third further pending referral is the Novartis case, C-354/19.
Published on: 28th Jan 2020

Patent

SPC

Health

CRISPR/CAS9 failed to edit EPO priority entitlement case law
By Nicolas BOUQUIN, French & European Patent Attorney and Lucile VERNOUX French & European Patent Attorney
VERNOUXBOUQUIN.PNG In a new twist in the CRISPR/Cas9 saga, European patent EP 2 771 468 was revoked in appeal on 16 January 2020 (T 0844/18). This patent covers an important aspect of the technology and its use in eukaryotes.
Published on: 28th Jan 2020

Patent

Health

Opinion on the patentability of your invention by the 5 IP5 Offices. It's now possible at the international stage!
By Soizic GUINDEUIL, Senior Associate.
Guindeuil_search.jpg The IP5 offices have launched a collaborative search and examination pilot project to provide a written opinion on the patentability of an invention by these five offices, as early as the international stage, and thus without waiting for the initiation of national phase examination procedures.
Published on: 22th May 2019

Patent

Patents

Patentability

Breaking News : the question of the patentability of plants/animals obtained exclusively by means of an essentially biological process has once again been referred o the EPO's enlarged board of appeal!
By Gabrielle FAURE-ANDRE and Philippe BESSIERE, French and European Patent Attorneys.
GAFPB.PNG It is now official: the President of the European Patent Office (EPO), António Campinos, has done what he said he would do… in asking, once again, the EPO’s Enlarged Board of Appeal to rule on the patentability exclusion introduced into new Rule 28(2) EPC.
Published on: 19th April 2019

Patent

Patentability of Biological Material

FICPI Position on Patent Law Harmonisation
Article co-authored by Jérôme COLLIN, Partner.
Collin_search.jpg FICPI was invited to a recent B+ Sub-Group meeting on 26 September 2018 to present its position on the three main patent law harmonisation topics currently under consideration: grace period, prior user rights, and conflicting applications.
In June, 2018 FICPI passed a resolution on conflicting applications and adopted an extensive position paper on these key harmonisation topics.
This article provides a brief background to FICPI’s consideration of these topics and summarises the positions reached.
Published on: 18th March 2019

Patent

What impact will a BREXIT without a withdrawal agreement as of March 30, 2019, have on your IP assets, in particular patents, trademarks & designs, domain names?
By Christian TEXIER, Frédérique FAIVRE PETIT, Sylvain THIVILLIER, Evelyne ROUX, Partners, Cécile PUECH, Senior Associate and Anne CHANTELOUP, Intellectual Property Lawyer.
CTFFPEVR.PNG UK MPs overwhelmingly rejected the negotiated exit agreement of the EU by 432 votes against 202 on Tuesday January 15, 2019.
Published on: 21th Jan 2019

Patent

Trademark

Designs

Domain Name

Brexit

PPH: all possibilities are not equal
By Cécile PUECH, Senior Associate.
C.PUECH.jpg Over time, accelerated examination programs under the PPH (Patent Prosecution Highway), have proliferated. But does this simplify the task of applicants when a first office considers certain claims to be acceptable? In addition to limitations associated with the fact that an accelerated examination under the PPH may only be requested prior to the start of the examination, it appears that the benefit of filing a PPH request varies according to the applicant’s expectations, the country concerned and sometimes even the technical field of the invention… Rather than systematically filing PPH requests, a case-by-case analysis seems to be more appropriate for optimizing the examination of patent applications.
Published on: 10th Jan 2019

Patent

35 USC § 101: Further clarification of patent subject-matter eligibility.
By Sara HAINES, US Patent Agent.
S.Haines.jpg Two recently issued USPTO memorandums further clarify aspects of patent subject-matter eligibility under 35 USC § 101. The Vanda memo1 specifies methods of treatment that should be considered to be patent eligible under step 2A of the Alice/Mayo test2 thereby avoiding any further analysis under step 2B, while the Berkheimer memo3 states that examiners must provide substantiated evidence when additional claim elements are considered to represent well-understood, routine, conventional activity in support of 35 USC § 101 rejections under step 2B.
Published on: 30th Oct 2018

Patent

Patentability of Biological Material

Biomarkers

European Patent Office : Patentability of inventions involving Artificial Intelligence
By Matthieu OBJOIS, Senior Associate.
OBJOIS_SEARCH.jpg By decision of the President of the European Patent Office (EPO) dated 25 July 2018 and pursuant to Article 10(2) EPC, the Guidelines for Examination have been amended in accordance with the policy of the EPO which provides for their revision on an annual basis. These Guidelines indicate the practices and procedures to be followed by both Applicants and Examiners, and are a useful tool for monitoring the evolution of EPO policy.
Published on: 4th Oct 2018

Patent

European and Unitary Patent

AI

Protection of Trade Secrets : Law No. 2018-670 of July 30th, 2018
By Christian Texier, Partner.
C.Texier 65x65.jpg Law No. 2018-670 of July 30th on the “Protection of Trade Secrets” was published in the Official Gazette, No. 0174 on July 31st 2018.
Published on: 25th Sept 2018

Patent

Patents

European and Unitary Patent

Proposal from the European parliament and council on copyright for a directive in the single digital market. Rejection or substantive debate coming?
By Christian TEXIER, Partner.
C.Texier 65x65.jpg It has been widely reported in the press in recent weeks that a proposal for a European Copyright Directive was rejected by the European Parliament on July 5th, 2018. What does this mean exactly?
Published on: 25th Sept 2018

Patent

Patents

European and Unitary Patent

Copyright

Disclaimers at the EPO: an update with decision G1/16
By Jérôme COLLIN, Partner
Collin_search.jpg On December 18, 2017, the Enlarged Board of Appeal published decision G1/16 on the allowability of disclaimers. This decision clarifies the requirements for allowing a so-called ‘undisclosed’ disclaimer at the European Patent Office. This article will provide a reminder of the background behind decision G/16, present the content of the decision and draw conclusions on the practice of disclaimers at the EPO.
Published on: 24th Jul 2018

Patent

Patents

European and Unitary Patent

Validation of European patents in Cambodge
An agreement allowing the validation of European patents for Cambodia entered into force on March 1, 2018, allowing inventors and companies filing an application for European patent, to ask for Cambodia validation.
Published on: 19th March 2018

Patent

European and Unitary Patent

Legislation

European patent

Draft French standard (NF X50-276) to facilitate the electronic exchange of data relating to intellectual property rights is subject to a public enquiry
By Marc LEVIEILS, Partner
Levieils_search.jpg Under AFNOR’s authority and in the framework of the Innovation Management Commission , the Working Group CN INNOV GT5 (moderated by Marc LEVIEILS) has prepared a draft French Standard (NF X50-276) to facilitate the electronic exchange of data relating to intellectual property rights.
Published on: 6th Sept 2017

Patent

Trademark

Standard

Data

Some news from this summer regarding the agreement on the unitary patent court
After Estonia on August 1st, 2017, Lithuania has ratified the agreement on the unitary patent court on August 24...
Published on: 5th Sept 2017

Patent

European and Unitary Patent

Unitary Patent

Unified Patent Court

The European Patent Office has Published the “Unitary Patent Guide”
By Stéphanie CELAIRE, Partner
Celaire_search.jpg The European Patent Office (EPO) has published the 1st edition of the "Unitary Patent Guide." This guide outlines the texts concerning applications for European patents with unitary effect, annual fees, entries in the Register for Unitary Patent Protection, languages and remedies in the event that the unitary effect is rejected. It also details the practical means by which these procedures will be handled by the EPO on the basis of the rules relating to Unitary Patent Protection (UPR).
Published on: 23th Aug 2017

Patent

European and Unitary Patent

Unitary Patent

Unified Patent Court

Declaration of “Sensitive” Inventions with the DGA: Clarified Procedure
by Julie TOUEG, European and French Patent Attorney
Toueg_search.jpg The obligation to declare patent applications for “sensitive” inventions is not new. The practical arrangements have recently been indicated in a Decree and an Order, and whose practical implications for applicants are summarized below.
Published on: 9th Aug 2017

Patent

Defense Security - DGA

Revision of the Patent Examination Guidelines in China
by Dan SHI, Chinese Patent Attorney
The State Intellectual Property Office (SIPO) of China recently issued Decision of the Revision to “Guidelines of Patent Examination” (“the Guidelines”). The Revision to the Guidelines (“the Revision”) will take effect from 1 April 2017.
Published on: 29th March 2017

Patent

Legislation

Unified Patent Court: Ratification by Italy, entry into force for the end of 2017 ?
by Sylvain THIVILLIER, Head of the Munich Office
v5570- Sylvain THIVILLIER.jpg On February 10, 2017, Italy became the 12th member state ratifying the International Agreement on a Unified Patent Court (UPC). Italy, who had initially expressed reservations regarding the project of a new European system for patents, composed of the Unitary Patent (UP) and the Unified Patent Court (UPC), now gives a strong message in ratifying the UPC agreement and we hope that this is an optimistic sign for a rapid entry into force of the UP and UPC
Published on: 14th Feb 2017

Patent

European and Unitary Patent

Unified Patent Court

Unitary Patent

European Patents soon to be valid in Cambodia!
by Julie TOUEG, French Patent Attorney
Toueg_search.jpg Following last year’s accession to the PCT (effective as of 8th December 2016), on 23rd January 2017 Cambodia signed an agreement with the EPO to extend the validity of European patents to Cambodia, upon request of the applicant.
Published on: 6th Feb 2017

Patent

European and Unitary Patent

Modifications to the Directives of the European Patent Office Practical Exam: Impact on Assignment Recordation
by Jérôme BRAQUEHAIS, Head of the Recordal Department
v2062-Jérôme BRAQUEHAIS.jpg As of 1st November 2016, the European Patent Office (EPO) Examination Directive that includes the acceptance conditions for recording an assignment underwent changes significantly altering the recordal procedure of an assignment at the EPO.
Published on: 2nd Feb 2017

Patent

Book: Unitary Patent and the Unified Patent Court (French only)
​The Patent system in Europe will undergo major changes with the upcoming entry into force of the agreements establishing the Unified Patent Court and the Unitary Patent. Download the outline (french only) or order the book on the link below.
Published on: 24th Jan 2017

Patent

European and Unitary Patent

Unified Patent Court

Unitary Patent

Legislation
Icon_Footer_Webpart.png For more information or to order the book

The European Patent Office Clarifies the Standard for Partial Priority
by Jérôme COLLIN, Partner
Collin_search.jpg In case G1/15 the Enlarged Board of Appeals of the European Patent Office has just released the order of its decision as follows: “Under the EPC, entitlement to partial priority may not be refused for a claim encompassing alternative subject-matter by virtue of one or more generic expressions or otherwise (generic “OR”-claim) provided that said alternative subject-matter has been disclosed for the first time, directly, or at least implicitly, unambiguously and in an enabling manner in the priority document. No other substantive conditions or limitations apply in this respect.”
Published on: 1st Dec 2016

Patent

European and Unitary Patent

Pitfalls that US origin cases experience in the EPO
By Sylvain THIVILLIER, head of Munich Office and Christine McCARTHY, Partner, BARNES & THORNBURG LLP
v5570- Sylvain THIVILLIER.jpg Dual protection of patentable innovations in the US and Europe has long strengthened the relationship between those economic markets and affected competition therein. However, patent applicants beginning their pursuit of protection with US origin applications at the United States Patent and Trademark Office (USPTO) often face significant but often avoidable challenges in protecting their innovations in the European Patent Office (EPO).
Published on: 18th Oct 2016

Patent

US Patent

Comparative law

Modification of the Terms for Refunding the Examination Fee of a European Patent Application
by Julie TOUEG, IP Attorney
TOUEG.jpg A decision of the Administrative Council of the European Patent Organisation relating to the refund of the examination fee, of 29 June 2016, amends Article 11 of the Rules Relating to Fees (RRF).
Published on: 26th Aug 2016

Patent

European and Unitary Patent

First Remarks as to the Implications on Intellectual Property Following the BREXIT vote of 24 June
This morning, Friday 24 June 2016, the British referendum result in favour of BREXIT was announced, meaning the United Kingdom has voted to leave of the European Union. What will be the initial consequences in the intellectual property field?
Published on: 24th Jun 2016

Patent

Contracts

Trademark

Designs

European and Unitary Patent

European Union trademark

Unified Patent Court: No Opt-Out Fee!
by Sylvain THIVILLIER, Head of the Munich Office
v5570- Sylvain THIVILLIER.jpg On 24 and 25 February 2016, the Preparatory Committee for the UPC met and agreed on a text stating the “Rules on Court fees and recoverable costs” linked to the UPC, in which it should be noted that the official fee for opting out of the exclusive jurisdiction of the UPC has been removed.
Published on: 2nd March 2016

Patent

European and Unitary Patent

Unified Patent Court

Legislation

Unitary Patent

Is 2016 the final stretch before the entry in force of the Unitary Patent and the Unified Patent Court?
By Christian TEXIER, Partner, and Sylvain THIVILLIER, Head of the Munich Office
TEXIER THIVILLIER.JPG The reference texts defining the Unitary Patent and the Unified Patent Court allow us already to identify certain general principles for these systems. During the last 2 years, the Preparatory Committee of the UPC has done tremendous work to draft the rules of implementation for these new systems, rules which should be adopted in the following (next few?) months.
Published on: 9th Feb 2016

Patent

European and Unitary Patent

Unified Patent Court

Unitary Patent

Advertising and Alcohol: The Supreme Court Acknowledges that the Impression of Pleasure is Allowed!
by Martine BLOCH-WEILL, Partner
v3588-Martine BLOCH WEILL.jpg We informed you last year of the judgment of the Versailles Court of Appeal (Ch 3, 3 April 2014 ANPAA/CIVB) which claimed that appearing “grumpy” was not imposed by the EVIN Law (see article). Hearing this case again the Supreme Court made a new judgement on 1st July 2015, at the end of which it reviews the strict position issued in its first judgement of 23rd February 2012.
Published on: 11th Dec 2015

Patent

Trademark

Designs

Advertising

Wine and Spirits

After Morocco, it is now Possible to Validate a European Patent in Moldova!
by Sylvain THIVILLIER, European and French Patent Attorney
v5570- Sylvain THIVILLIER.jpg The opening of the European Patent to non-member states - which officially started on 1 March 2015 with the entry into force of the validation agreement concluded between the European Patent Office (EPO) and Morocco – is continuing. A new validation agreement, this time with the Republic of Moldova (MD) entered into force on 1 November 2015.
Published on: 13th Nov 2015

Patent

Advertising and Alcohol: Trial Judges Declare There is No Need to Get Cranky!
by Martine BLOCH-WEILL, Partner
v3588-Martine BLOCH WEILL.jpg The Versailles Court of Appeal (Ch 3, 3 April 2014 ANPAA/CIVB) upon referral after appeal (Cass, 1st civ, 23 February 2012) rejected the strict interpretation made by the Supreme Court as to the provisions in the Evin Law relating to advertising requirements for alcoholic beverages.
Published on: 30th Jul 2015

Patent

Trademark

Designs

Advertising

Wine and Spirits

Human Embryonic Stem Cell Patentability in Europe and the United States
By Gabrielle FAURE-ANDRE, French and European Patent Attorney
v2387-Gabrielle FAURE-ANDRE.jpg Today, the position of the European Patent Office (EPO) as to the patentability of human embryonic stem cells (hESCs) is clear. A European patent can only protect an invention involving such cells if, at the "relevant date", the cells could be obtained by means other than the destruction of a human embryo.
Published on: 25th Jun 2015

Patent

Patentability

Patentability of Biological Material

How to Validate a European Patent in Morocco?
by Sylvain THIVILLIER, European and French Patent Attorney
v5570- Sylvain THIVILLIER.jpg As indicated in our 10 March 2015 brief, the President of the European Patent Office (EPO) and the Moroccan Minister of Industry signed in December 2010 an agreement relating to the validation of European patents. This agreement entered into force on 1 March 2015.
Published on: 21th April 2015

Patent

Amendments Before the European Patent Office
by Sylvain THIVILLIER, European and French Patent Attorney
v5570- Sylvain THIVILLIER.jpg The possibility of amending a patent application has been enshrined in the European Patent Convention (EPC) as a right given to any applicant. The EPC however also provides safeguards to preserve the rights of third parties. This paper aims at explaining how the safeguard provided by Article 123(2) EPC is applied at the European Patent Office (EPO).
Published on: 19th March 2015

Patent

European and Unitary Patent

Validation of European Patents in Morocco
By Christian TEXIER, Partner
C.Texier 65x65.jpg For European and International (PCT) patent applications filed on or after 1 March 2015 the option to validate in Morocco will be available, thus obtaining protection in that territory.
Published on: 12th March 2015

Patent

European and Unitary Patent

Legislation

The Unpatentability of a Dosage Claim is no Longer a French Exception
By Anne BOGARD BOUTARIC, Partner
v2191-Anne BOUTARIC.jpg There is no doubt that substances or compounds used in medical treatments are explicitly recognised as meeting the criterion for patentability.
Published on: 25th Feb 2015

Patent

Patentability

Pharmacy

New tools to get your patents issued faster
By Cécile PUECH, European and French Patent Attorney
C.PUECH.jpg Recently, we have seen a growing number of tools that allow French and other European applicants to speed up the issuing procedure for some of their patents in various countries; this is particularly due to the development of PPH (Patent Prosecution Highway) programmes, which the European Patent Office (EPO) is involved in.
Published on: 9th Feb 2015

Patent

Legislation

Accelerated Examination

The US patent system (still) requires more than the laws of Nature…
By Frédérique FAIVRE PETIT, Partner
vignette F.FAIVRE-PETIT (3).jpg US patent law is probably one of the most lenient in the world: it provides for no exclusion in principle and requires solely that an invention must be, as a first condition, useful (within the meaning of 35 USC 101) before it is examined from the viewpoint of "conventional" patentability criteria such as novelty and inventive step.
Published on: 28th Jul 2014

Patent

US Patent

Patentability of Biological Material

Are Your Industrial Property Rights Protected in French Polynesia?
By Christian TEXIER, Partner and Nicolas DEMILLY, French and European Trademark and Design Attorney
TEXIER DEMILLY.JPG The organic law no. 2004-192 of 27 February 2004 laying down the autonomous status of French Polynesia transferred the authority in all Industrial Property matters to this territory.
Published on: 7th Jul 2014

Patent

Trademark

Designs

Legislation

Diagnostic Method : Confirmation in the United States of the difficulty in obtaining protection
By Frédérique FAIVRE PETIT, Partner
vignette F.FAIVRE-PETIT (3).jpg On 30 October 2013, the District Court for the Northern District of California (DCNDC) invalidated a patent relating to a diagnostic method, thus confirming the difficulty in protecting this type of invention in the United States.
Published on: 13th Dec 2013

Patent

Diagnostic methods

The product covered by an SPC - a definition on a case-by-case basis?
By Anne BOUTARIC, Senior Associate
v2191-Anne BOUTARIC.jpg By only reading Council Regulation (EC) No. 1768/92, the definition of a product eligible to be covered by an SPC may seem clear. However, the scope of this definition is still being debated, and the MEDEVA decision requires more preliminary ruling.
Published on: 3rd Dec 2013

Patent

SPC

Legislation

Filing of Divisional Applications : Amendement of the implementing regulations to the Europaen Patent Convention
By Frédérique DURIEUX, French and European Patent Attorney
v4255-Frédérique DURIEUX-RIVAS.jpg The Administrative Council of the European Patent Office has just adopted an amendment of the requirements for the filing of divisional applications.
Published on: 5th Nov 2013

Patent

European and Unitary Patent

Legislation

Prescription of an action in patent invalidation
By Francis AHNER, Partner
F.Ahner 65x65.jpg Up to the entry into force of new Article 2224 of the French “Code Civil”, it was generally accepted that an action for invalidation of a patent was subject to the thirty year liability period of common law.
Published on: 16th Oct 2013

Patent

Legislation

MYRIAD: Over 30 years of practice is being revisited by the United States Supreme Court:Isolated DNA is now longer patentable! Hard times for United States protected biotechnology inventions
Frédérique FAIVRE PETIT, Partner
vignette F.FAIVRE-PETIT (3).jpg The Biotechnology industry has been decidedly mistreated by recent decisions in the US which are disrupting over 30 years of practice concerning the protection of inventions relating to or involving genes. This is creating a great uncertainty about the value of corresponding US patents.
Published on: 1st Jul 2013

Patent

US Patent

Bioethics

Biotechnologies

Patentability of Biological Material

Diagnostic methods

Biomarkers

Patentability of Human Embryonic Stem Cell Lines
By Gabrielle FAURE-ANDRE, French Patent Attorney
v2387-Gabrielle FAURE-ANDRE.jpg While the Brüstle vs. Greenpeace decision does not aim to influence the European Patent Office (EPO), we nevertheless anticipated that it may well result in the hardening of the EPO’s position concerning the patentability of human embryonic stem cell lines...
Published on: 14th Jun 2013

Patent

Bioethics

Biotechnologies

Patentability of Biological Material

Legislation

Third Party Observations: a weapon to integrate in your IP strategy ?
By Stéphanie CELAIRE, Senior Associate
v2417-Stéphanie CELAIRE.jpg As rare as it is old, having been established in the French IP Code in 1968, the third-party observation system is currently experiencing a revival, thanks, in part, to a push by various IP offices to try and regenerate interest in the system.
Published on: 15th May 2013

Patent

Third party Observation

Comparative law

Unitary Patent and Unified Patent Court : Europe adopts two new tools for innovation
By Christian TEXIER, Partner
C.Texier 65x65.jpg The Council of the European Union adopted Monday December 17 2012, two regulations relating to the creation of unitary patent protection and its translation arrangements.
Published on: 18th Dec 2012

Patent

European and Unitary Patent

Unified Patent Court

Translation, Language

Myriad : Second confirmation of patentability of isolated DNA. Will this be the final chapter?
By Frédérique FAIVRE PETIT, Partner
vignette F.FAIVRE-PETIT (3).jpg For the third time, an American Court has decided on patentability of «genes», confirming the previous decision, which reversed the first one…. But let us start from the beginning.
Published on: 19th Sept 2012

Patent

Patentability of Biological Material

Are patents and diagnostic methods compatible? Europe - United States - Canada - Brazil - India - China - Japan - Korea - Australia
By FAIVRE PETIT Frédérique, Partner
vignette F.FAIVRE-PETIT (3).jpg Whereas one might think ideally medicine should one day be able to diagnose everything, this has not been achieved yet, although... The pharmaceutical and diagnosis industries...
Published on: 2nd Jul 2012

Patent

Diagnostic methods

Comparative law

Pharmacy

Biomarkers

Patentability of Biological Material

Request for Limitation of a Patent: the Court of Cassation pronounces an eagerly-awaited decision
By Franck TETAZ, Partner
F.Tetaz 65x65.jpg the Court dismissed the appeal lodged by TEISSEIRE against the judgment of the Paris Court of Appeal rejecting its request for annulment of the decision of the Director of INPI allowing ROUTIN a limitation of its patent relating to «sugar-free syrup».
Published on: 7th Jun 2012

Patent

Jurisprudence

Limitation

MAYO V. PROMETHEUS
By Franck TETAZ, Partner
F.Tetaz 65x65.jpg How the Supreme Court of the United States of America has made a distinction between a patentable invention and a scientific discovery, thus creating new difficulties in protecting inventions in the area of diagnostic research in this country.
Published on: 16th May 2012

Patent

Patentability

Diagnostic methods

Pharmacy

Patentability of Biological Material

Biomarkers

Patentability of embryonic stem cells - after the European Patent Office, the European Court of Justice gives its opinion
By Gabrielle FAURE-ANDRE, IP engineer
v2387-Gabrielle FAURE-ANDRE.jpg Pursuant to Article 6(2)(c) of Directive 98/44/EC of the European Patent Convention (EPC), the use of «human embryos» for industrial or commercial purposes is not patentable.
Published on: 14th Feb 2012

Patent

Patentability of Biological Material

Does a priority right exist without experimental results?
By Nicolas BOUQUIN, European Patent Attorney
BOUQUIN.jpg In the field of biotechnologies, inventions are routinely disclosed in patent applications before any result has been obtained.
Published on: 6th Feb 2012

Patent

Priority right, First filing

Experimental results

The French Supreme Court and the Secrets of the London Agreement
By Jean-Robert CALLON DE LAMARCK, Partner
J.R.Callon 65x65.jpg Commentary on the Judgement of the French Court of Cassation dated 2 November 2011
Published on: 2nd Nov 2011

Patent

European and Unitary Patent

Translation, Language

The United States are changing their patent rules
By Marie AUDREN and Barbara CASADEWALL, European and French Patent Attorneys
After a decade of discussions for reforming patent legislation, the United-States finally passed the Leahy-Smith America Invents Act. The bill was signed by President Obama on September 16, 2011.
Published on: 1st Sept 2011

Patent

US Patent

Legislation

G2/07 - How EPO's Enlarged Board of Appeal interpretes the expression "essentially biological process" under A.53(B) EPC
By Franck TETAZ, Partner, and Lucile VERNOUX, European Patent Attorney, Cabinet REGIMBEAU
The question of the patentability of plants was a struggle of the last century.
Published on: 14th Jun 2011

Patent

Plant Breeding

Patentability

The European Patent is doing well… and the draft of the “Unitary” Patent is going forward…
By Frédérique FAIVRE PETIT, Partner, European and French Patent Attorney - Cabinet REGIMBEAU
vignette F.FAIVRE-PETIT (3).jpg In 2010, the number of European patent applications reached the highest level in the Office’s 34 year history, with some 235 000 filings representing an 11% increase on patent applications filed in 2009.
Published on: 27th April 2011

Patent

European and Unitary Patent

Procedure to limit the scope of a patent before the INPI
By Francis AHNER, Partner, French & European Patent Attorney, Cabinet REGIMBEAU
F.Ahner 65x65.jpg The latest version of the European Patent Convention (EPC) has provided patent owners with the opportunity to narrow the protection conferred by their claims after grant of the patent.
Published on: 15th April 2011

Patent

Limitation

Notice on Decision G2/08
By Barbara Casadewall and Isabelle Mendelsohn, European and French Patent Attorneys - Cabinet REGIMBEAU
v B.CASADEWALL.jpg Decision G 2/08 issued by the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) on 19 February 2010 was particularly awaited within the pharmaceutical field.
Published on: 3rd Jan 2011

Patent

Pharmacy

Protection of shapes: Patents? Designs and copyright? Trademarks?
By Aymeric Vienne, European and French Patent Attorney and Evelyne Roux, Partner - Cabinet REGIMBAU
ROUX_SEARCH_2013.jpg While it is true that the law of designs naturally springs to mind where protection of the shape of a product is concerned, is it possible to protect the shape of your products using patent or trademark law?
Published on: 19th May 2010

Patent

Trademark

Designs

Shape

G1/07 : Answers, and answers between the lines
By Stéphanie Célaire - European and French Patent Attorney - Cabinet REGIMBEAU
v2417-Stéphanie CELAIRE.jpg Decision G001/07 was eagerly awaited in the field of medical imaging methods for diagnostic purposes.
Published on: 8th April 2010

Patent

Diagnostic methods

Pharmacy

Patentability of Biological Material

Jointly-owned patents – Part 1: the rules of the Intellectual Property Code
By Isabelle Pinaud, European and French Trademark Attorney - Cabinet REGIMBEAU
I.PINAUD.jpg A growing number of patents are now filed as joint property. These jointly-owned patents often result from research programmes carried out jointly by partners from very different backgrounds
Published on: 23th March 2010

Patent

Contracts

Collaborative innovation

Patent : Choosing the Country of first filing – Obligations of a French Resident Applicant
By Franck TETAZ, Partner, Cabinet REGIMBEAU
F.Tetaz 65x65.jpg The choice of the « country » for filing depends both on geographical and national limitations and on strategic and financial approaches.
Published on: 1st March 2010

Patent

IP Budget

Priority right, First filing

Enantiomers – Revocation of a patent on enantiomer (-) for lack of enablement
By Francis Ahner, Partner and Anne Boutaric, European and French Patent Attorney
Recently, the validity of a patent claiming an enantiomer of a known racemic compound was discussed for the first time before the Paris Court (Tribunal de Grande Instance – 1st instance; decision issued on October 6th, 2009).
Published on: 22th Oct 2009

Patent

Drugs

Pharmacy

Laws on Bioethics in France
By Frédérique Faivre Petit, French and European Patent Attorney, Partner - Cabinet REGIMBEAU
vignette F.FAIVRE-PETIT (3).jpg Laws on Bioethics were first laid down in France in 1994. The principle then set out by the law-maker was that they should be reviewed after 5 years.
Published on: 4th Sept 2009

Patent

Bioethics

Patentability of Biological Material

Biomarkers

Does the new limitation procedure for the European patent present any dangers?
F.Ahner 65x65.jpg The new European Patent Convention of 29th November 2000 called “EPC 2000” will come into force by 13th December 2007 at the latest.
Published on: 25th Jul 2009

Patent

Limitation

Directive 2004/48/CE of 29 April 2004 on the enforcement of Intellectual Property rights : implementation in France - definitive bill adopted by the Parliament
v2191-Anne BOUTARIC.jpg The measures are facilitated in order to prevent the continuing alleged infringement of intellectual property rights before obtaining a decision on the merits, such as an interlocutory injunction.
Published on: 7th Jul 2009

Patent

Infringement

Seizure of goods

European Patent Office : new provisions introducing time limites for the filing of divisional applications
J.R.Callon 65x65.jpg The Administrative Council of the European Patent Office agreed last 25th March to new provisions introducing time limits for the filing of divisional applications.
Published on: 20th May 2009

Patent

Divisional applications

New procedure in dealing with petition for review by the enlarged board of appeal set out in Article 112 bis-EPC 2000
By Francis AHNER, Partner, European Patent Attorney, Cabinet REGIMBEAU
F.Ahner 65x65.jpg Under the old EPC 1973, decisions or opinions of the Enlarged Board of Appeal could only be petitioned at the request of a board of appeal or of the President of the EPO, mainly in order to ensure uniform application of the law enacted by the EPC.
Published on: 6th Jan 2009

Patent

Petition for review

How to determine the true inventor ?
By Isabelle MENDELSOHN, IP Attorney, Cabinet REGIMBEAU And Franck TETAZ, Partner, Cabinet REGIMBEAU
F.Tetaz 65x65.jpg Which employer, licensing, IP or R&D department of a company has never been faced with the difficult task of designating the inventors when filing a patent application?
Published on: 1st Feb 2008

Patent

Inventorship

Case G 2/07 : Coming soon, an interpretation of the expression « Essentially biological process» by the EPO's Enlarged Board of Appeal
By Franck TETAZ, Partner, Cabinet REGIMBEAU And Lucile VERNOUX, IP Engineer, Cabinet REGIMBEAU
v5671- Lucille VERNOUX.jpg Decision G 1/98, later taken up in the “biotechnologies” directive, validated the patentability of plants produced through genetic engineering and their preparation processes when they are not limited....
Published on: 1st Feb 2008

Patent

Plant Breeding

Patentability

Patentability of Biological Material

False Divisional applications, but real continuation applications in Europe : Should Limits be imposed ?
J.R.Callon 65x65.jpg This summer, the Enlarged Board of Appeal of the European Patent Office made two long-awaited decisions on divisional applications (G1/05 and G1/06).
Published on: 1st Oct 2007

Patent

Divisional applications